Sputum induction in corticosteroid-dependant asthmatics: Risks and airway cellular profile

Asian Pacific Journal of Allergy and Immunology

Volumn 23, Issue 4, 2005, Pages 189-196

  Loh, Li Cher ^a   Kanabar, V ^b   D'Amato, M ^b   Barnes, N C ^c   O'Connor, B J ^b  

^a INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c LONDON CHEST HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; CORTICOSTEROID; CYCLOSPORIN A; IPRATROPIUM BROMIDE; PREDNISOLONE; SALBUTAMOL; SALMETEROL; SODIUM CHLORIDE; THEOPHYLLINE;

ADULT; ARTICLE; ASTHMA; BRONCHOSPASM; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DRUG DEPENDENCE; DRUG MEGADOSE; DRUG RESPONSE; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOPATHOGENESIS; INHALATION TEST; MALE; MEDICAL NEBULIZER; NEUTROPHIL; RESPIRATORY TRACT INFLAMMATION; RISK FACTOR; SPUTUM CYTODIAGNOSIS; TREATMENT FAILURE;

ADRENAL CORTEX HORMONES; ADULT; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHODILATOR AGENTS; BUDESONIDE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; SALINE SOLUTION, HYPERTONIC; SPUTUM;

EID: 33645284209     PISSN: 0125877X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Pizzichini E, Pizzichini M, Efthimiadis A, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996; 154: 308-17.
2. Spanevello A, Migliori GB, Sharara A, et al. Induced sputum to assess airway inflammation: a study of reproducibility. Clin Exp Allergy 1997; 27: 1138-44.
3. in't Veen JC, de Gouw HW, Smits HH, et al. Repeatability of cellular and soluble markers of inflammation in induced sputum from patients with asthma. Eur Respir J 1996; 9: 2441-7.
4. Pizzichini MM, Pizzichini E, Clelland L, et al. Sputum in severe exacerbations of asthma: kinetics of inflammatory indices after prednisone treatment. Am J Respir Crit Care Med 1997; 155: 1501-8.
5. de la Fuente PT, Romagnoli M, Godard P, Bousquet J, Chanez P. Safety of inducing sputum in patients with asthma of varying severity. Am J Respir Crit Care Med 1998; 157: 1127-30.
6. Grootendorst DC, van den Bos JW, Romeijn JJ, et al. Induced sputum in adolescents with severe stable asthma. Safety and the relationship of cell counts and eosinophil cationic protein to clinical severity. Eur Respir J 1999; 13: 647-53.
7. Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 1999; 160: 1532-9.
8. Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Eng] J Med 1990; 323: 1033-9.
9. Ronchi MC, Piragino C, Rosi E, et al. Do sputum eosinophils and ECP relate to the severity of asthma? Eur Respir J 1997; 10: 1809-13.
10. Fujimoto K, Kubo K, Matsuzawa Y, Sekiguchi M. Eosinophil cationic protein levels in induced sputum correlate with the severity of bronchial asthma. Chest 1997; 112: 1241-7.
11. Wenzel SE, Szefler SJ, Leung DY, Sloan SI, Rex MR, Martin RJ. Bronchoscopic evaluation of severe asthma. Am J Respir Crit Care Med 1997; 156: 737-43.
12. International consensus report on diagnosis and treatment of asthma. National Heart, Lung, and Blood Institute, National Institutes of Health. Bethesda, Maryland 20892. Publication no. 92-3091, March 1992.
13. Tattersfield AE, Holmes W. Who should look after asthma? Thorax 1995; 50: 597-9.
14. British Thoracic Society Guidelines on the management of asthma. Thorax 1993; 48: S1-S24.
15. Pin I, Gibson PG, Kolendowicz R, et al. Use of induced sputum cell counts to investigate airway inflammation. Thorax 1992; 47: 25-9.
16. Fahy JV, Liu J, Wong H, Boushey HA. Analysis of cellular and biochemical constituents of induced sputum after allergen challenge: a method for studying allergic airway inflammation. J Allergy Clin Immunol 1994; 93: 1031-9.
17. Sont JK, Booms P, Bel EH, Vandenbroucke JP, Sterk PJ. The severity of breathlessness during challenges with inhaled methacholine and hypertonic saline in atopic asthmatic subjects. The relationship with deep breath-induced bronchodilation. Am J Respir Crit Care Med 1995; 152: 38-44.
18. Makker HK, Holgate ST. Relation of the hypertonic saline responsiveness of the airways to exercise induced asthma symptom severity and to histamine or methacholine reactivity. Thorax 1993; 48: 142-7.
19. Bacci E, Cianchetti S, Paggiaro PL, el al. Comparison between hypertonic and isotonic saline-induced sputum in the evaluation of airway inflammation in subjects with moderate asthma. Clin Exp Allergy 1996; 26: 1395-1400.
20. Twaddell SH, Gibson PG, Carty K, Woolley KL, Henry RL. Assessment of airway inflammation in children with acute asthma using induced sputum. Eur Respir J 1996; 9: 2104-8.
21. Tarodo de la Fuente P, Romagnoli M, Carlsson L, Godard P, Bousquet J, Chanez P. Eosinophilic inflammation assessed by induced sputum in corticosteroid- dependent asthma. Respir Med 1999; 93: 183-9.
22. Louis R, Lau LC, Bron AO, Roldaan AC, Radermecker M, Djukanovic R. The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med 2000; 161: 9-16.
23. Green RH, Brightling CE, Woltmann G, Parker D, Wardlaw AJ, Pavord ID. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 2002; 57: 875-9.
24. Gibson PG, Simpson JL, Saltos N. Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 2001: 119: 1299-300.
25. Woolley KL, Gibson PG, Carty K, Wilson AJ, Twaddell SH, Woolley MJ. Eosinophil apoptosis and the resolution of airway inflammation in asthma. Am J Respir Crit Care Med 1996; 154: 237-43.
26. Meagher LC, Cousin JM, Seckl JR, Haslett C. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol 1996; 156: 4422-8.